Recent trends in the management of ischaemic heart disease
Datey, K.K.; Kapadia, N.M.; Dalvi, C.P.
Journal of the Association of Physicians of India 22(10): 759-765
1974
ISSN/ISBN: 0004-5772 PMID: 4448810 Document Number: 80579
Document emailed within 1 workday
Related Documents
Hughes, K. 1986: Trends in mortality from ischaemic heart disease in Singapore, 1959 to 1983 International Journal of Epidemiology 15(1): 44-50Yu, T.S.; Wong, S.L.; Lloyd, O.L.; Wong, T.W. 1995: Ischaemic heart disease: trends in mortality in Hong Kong, 1970-89 Journal of Epidemiology and Community Health 49(1): 16-21
Cleland, W.P. 1978: Surgical management of ischaemic heart disease British Journal of Clinical Practice 32(3): 67-72
Tulpule, T.H.; Shah, H.M.; Shah, S.J.; Haveliwala, H.K. 1971: Yogic exercises in the management of ischaemic heart disease Indian Heart Journal 23(4): 259-264
Purcell, H.; Fox, K. 1993: Potassium channel activators in the management of ischaemic heart disease: a focus on nicorandil British Journal of Clinical Practice 47(3): 150-154
Yarnell, J.W.; Limb, E.S.; Layzell, J.M.; Baker, I.A. 1992: Height: a risk marker for ischaemic heart disease: prospective results from the Caerphilly and Speedwell Heart Disease Studies European Heart Journal 13(12): 1602-1605
Golan, D.T.; Kursbaum, A. 1976: Anti-heart autoantibodies in ischaemic heart disease patients Clinical and Experimental Immunology 26(1): 86-90
1997: Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group Lancet 349(9049): 375-380
Nony, P.; Boissel, J.P.; Girard, P.; Leizorovicz, A.; Lievre, M.; Chifflet, R. 1992: Relative efficacy of angiotensin converting enzyme inhibitors on mortality of patients with congestive heart failure: implications of randomized trials and role of the aetiology (ischaemic or non-ischaemic) of heart failure European Heart Journal 13(8): 1101-1108
Bashir, R.; Khan, A.; Yousaf, M. 1996: Angiographically documented coronary artery disease in asymptomatic middle aged men suspected of silent ischaemic heart disease Jpma. Journal of the Pakistan Medical Association 46(10): 225-228
Lhotka, J.; Stuchlíková, E.; Klimesová, A. 1971: Changes in the pericardium in ischaemic heart disease Acta Universitatis Carolinae. Medica 17(7): 573-580
Christie, J. 2011: Ischaemic heart disease prevention NursingTimes 107(30-31): 20
Constantine, G.R.; Thenabadu, P.N. 1996: Use of aspirin in ischaemic heart disease Ceylon Medical Journal 41(4): 167-168
Law, M.R.; Wald, N.J. 1999: Homocysteine and ischaemic heart disease Haematologica 84 Suppl Eha-4: 57-60
Violi, F.; Iuliano, L.; Iullano, L. 1997: Antioxidants and ischaemic heart disease Lancet 350(9078): 667-668
Wojtczak, A.; Skretkowicz, J. 2007: Genetics in ischaemic heart disease Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 23(133): 5-8
Van Assche, F.A.; Aerts, L.; Holemans, K. 1994: Low birthweight and ischaemic heart disease Lancet 343(8899): 731-732
Tauheed, S.; Shoaib, S.; Kamal, A. 1993: Haematocrit values in ischaemic heart disease Jpma. Journal of the Pakistan Medical Association 43(2): 34-35
Tan, A.T.; Koh, T.H. 1990: Coronary angioplasty in ischaemic heart disease Annals of the Academy of Medicine Singapore 19(1): 109-112
Hansen, G.M.ør.; Holmstrup, P.; Tolker-Nielsen, T.; Køllgaard, T.; Nielsen, C.H.; Givskov, M.; Hansen, P.R. 2014: A possible correlation between periodontitis and ischaemic heart disease Ugeskrift for Laeger 176(18)